Focus on potential partnership and strategic opportunities for the Company’s stem cell therapy program for Alzheimer’s disease Recent Type B meeting with FDA provided alignment on a planned single, ...

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF), a leading Phase III clinical-stage biotechnology company developing autologous ...

Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in tissue-targeted AAV gene therapy, today announces the ...

Mobile genetic elements such as CAST provide an idea of the coding potential of nature for genome manipulation. It is in the ...

BURLINGAME, CA, UNITED STATES, May 20, 2025 /EINPresswire.com/ -- Biotechnology Market is estimated to be valued at USD 1,034.63 Bn in 2025 and is expected to reach USD 2,330.47 Bn in 2032, exhibiting ...

Researchers have developed a novel technology that allows the distribution of components within a single cell to be accurately detected and visualized. Positioning a t-SPESI (tapping-mode scanning ...

MicroRNA-27a has been shown to stimulate both the wingless-type integration site family, or Wnt signaling, and the bone morphogenetic protein pathways to actively promote bone regeneration, according ...

Researchers have flagged some "promising" new approaches that could save lives and dramatically improve patient recovery. The ...

PROCEPT BioRobotics specializes in surgical robotic solutions for the urology market, with Q1 revenues up 55.5% ...

Swarming is one of the principal forms of bacterial motility facilitated by flagella and surfactants. It plays a distinctive ...